Amrutanjan Health Care Limited has informed the Exchange regarding 'Rephrasing of ESOP'.
AMRUTANJAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Amrutanjan Health Care has informed the stock exchanges that it is rephrasing the Second Phase (ESOP 2) of its existing Employees Stock Option Scheme 2020. The change was approved by the company's Nomination and Remuneration Committee / Compensation Committee on April 17, 2026, via a resolution. The company has not disclosed further details such as revised grant size, exercise price, or timeline in this filing. The intimation is being made under SEBI Listing Obligations and Disclosure Requirements (Regulation 30). Shareholders will need to wait for more details on how the scheme terms are being altered.
This is a procedural update on the company's employee stock option plan and is unlikely to have an immediate material impact on shareholders or the stock price. Investors should watch for follow-up filings that clarify the actual changes to ESOP 2 terms.